Mathew Stanley

Mathew Stanley

Auto-generated profile, based on publicly available information

Mathew Stanley

Division of Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2016 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
KPKuan-Chuan Pao
Kuan-Chuan Pao
MSMathew Stanley
Mathew Stanley
CHCong Han
Cong Han
YLYu-Chiang Lai
Yu-Chiang Lai
PMPaul Murphy
Paul Murphy
SVSatpal Virdee
Satpal Virdee
Probes of E3 ligase transthiolation activity reveal the hierarchy of phosphorylation events leading to cellular parkin activation and show that disease-linked parkin mutants have impaired transthiolation activity. E3 ligases represent an important class of enzymes, yet there are currently no chemical probes for profiling their activity. We develop a new class of activity-based probe by re-engineering a ubiquitin-charged E2 conjugating enzyme and demonstrate the utility of these probes by profiling the transthiolation activity of the RING-in-between-RING (RBR) E3 ligase parkin in vitro and in cellular extracts. Our study provides valuable insight into the roles, and cellular hierarchy, of distinct phosphorylation events in parkin activation. We also profile parkin mutations associated with patients with Parkinson's disease and demonstrate that they mediate their effect largely by altering transthiolation activity. Furthermore, our probes enable direct and quantitative measurement of endogenous parkin activity, revealing that endogenous parkin is activated in neuronal cell lines (≥75%) in response to mitochondrial depolarization. This new technology also holds promise as a novel biomarker of PINK1-parkin signaling, as demonstrated by its compatibility with samples derived from individuals with Parkinson's disease.

3 August 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
PMPeter D. Mabbitt
Peter D. Mabbitt
ALAndrea Loreto
Andrea Loreto
MDMarc-André Déry
Marc-André Déry
AFAdam J. Fletcher
Adam J. Fletcher
MSMathew Stanley
Mathew Stanley
SVSatpal Virdee
Satpal Virdee

1 June 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DLDeborah E. A. Lockhart
Deborah E. A. Lockhart
MSMathew Stanley
Mathew Stanley
OROlawale G. Raimi
Olawale G. Raimi
DRDavid A. Robinson
David A. Robinson
DBDominika Boldovjakova
Dominika Boldovjakova
DADaan MF Van Aalten
Daan MF Van Aalten
Aspergillus fumigatus is a human opportunistic fungal pathogen whose cell wall protects it from the extracellular environment including host defenses. Chitin, an essential component of the fungal cell wall, is synthesized from UDP-GlcNAc produced in the hexosamine biosynthetic pathway. As this pathway is critical for fungal cell wall integrity, the hexosamine biosynthesis enzymes represent potential targets of antifungal drugs. Here, we provide genetic and chemical evidence that glucosamine 6-phosphate N-acetyltransferase (Gna1), a key enzyme in this pathway, is an exploitable antifungal drug target. GNA1 deletion resulted in loss of fungal viability and disruption of the cell wall, phenotypes that could be rescued by exogenous GlcNAc, the product of the Gna1 enzyme. In a murine model of aspergillosis, the Δgna1 mutant strain exhibited attenuated virulence. Using a fragment-based approach, we discovered a small heterocyclic scaffold that binds proximal to the Gna1 active site and can be optimized to a selective submicromolar binder. Taken together, we have provided genetic, structural, and chemical evidence that Gna1 is an antifungal target in A. fumigatus.

8 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DLDeborah E.A. Lockhart
Deborah E.A. Lockhart
MSMathew Stanley
Mathew Stanley
OROlawale G. Raimi
Olawale G. Raimi
DRDavid A. Robinson
David A. Robinson
DBDominika Boldovjakova
Dominika Boldovjakova
DADaan MF Van Aalten
Daan MF Van Aalten
Summary: Aspergillus fumigatusis a human opportunistic fungal pathogen with a cell wall that protects it from the extracellular environment. Chitin, an essential cell wall component, is synthesised from UDP-GlcNAc that is produced by the hexosamine biosynthetic pathway. Here, we provide genetic and chemical evidence that glucosamine 6-phosphateN-acetyltransferase (Gna1), a key enzyme in this pathway, is an exploitable antifungal drug target. Deletion ofGNA1results in loss of viability and disruption of the cell wall, phenotypes that can be rescued by the product of the enzyme. In a murine model of aspergillosis, theΔgna1mutant strain attenuates virulence. Using a fragment-based approach, we discovered a small heterocyclic scaffold that binds proximal to the active site and can be optimised to a selective sub-micromolar binder. Taken together, we have provided genetic, structural and chemical evidence for Gna1 as an antifungal target inAspergillus fumigatus.